Latest News from NPR

on:

NCPR is supported by:

 
Hourly Newscast
4 min., 45 sec.

Programs

Latest program rundown

Coming up:

Latest Features:
August 1, 2014 | NPR · Renee Montagne talks with the head of the Centers for Disease Control and Prevention, Dr. Thomas Frieden, for the latest news about the Ebola outbreak in West Africa.
 
August 1, 2014 | NPR · CIA director John Brennan apologized to Sen. Dianne Feinstein, who had accused the CIA of spying on her committee's computers. Brennan at first denied it.
 
August 1, 2014 | NPR · It's one of the most popular items, but often it seems to be as far as humanly possible from the entrance. The Planet Money team looks at two very different theories about why that is.
 

Latest program rundown

Coming up:

Latest Features:
August 1, 2014 | NPR · House Republicans are delaying their August recess, sticking around Washington to try passing a bill meant to address the border crisis. Democrats and President Obama have already voiced their opposition to the bill on the table.
 
August 1, 2014 | NPR · Regular political commentators, E.J. Dionne of The Washington Post and David Brooks of The New York Times, discuss the beleaguered border bill in the House and the shattered cease-fire in Gaza.
 
August 1, 2014 | NPR · Fighting in Gaza took an ominous turn Friday, as a 72-hour humanitarian cease-fire fell apart within 90 minutes and the Israeli military announced its belief that one of its soldiers was captured by Hamas militants.
 

Latest Saturday rundown




WE Saturday Feature

July 26, 2014 | NPR · Hezbollah has been a longtime ally of Hamas, but during this most recent conflict between Israel and Gaza they've taken a sideline role. NPR's Scott Simon talks to the BBC's Kim Ghattas in Beirut.
 

Latest Sunday rundown


WE Sunday Feature

July 27, 2014 | NPR · Fighting in Ukraine near the crash site of Malaysia Airlines Flight MH17 has international investigators staying away. NPR's Arun Rath talks with OSCE's Michael Bociurkiw about the investigation.
 

Latest program rundown

Coming up:

Pharmaceuticals

Jul 25, 2014 — A husband and wife who are doctors have been working on fact boxes for drugs that, like nutrition labels for foods, would more concisely convey a medicine's benefits and risks.
Launch in player | Comments |
Jul 11, 2014 — There's overmedicating and self-medicating, but some vets are "de-medicating." Prescribed multiple drugs to deal with PTSD and pain, they've stopped taking them — without authorization.
Launch in player | Comments |
Jun 23, 2014 — Drugmakers offer medicines at a bargain price to hospitals that treat large numbers of poor patients. Hospitals sometimes resell the drugs at full price and make hefty profits.
Launch in player | Comments |
May 20, 2014 — Medicare gives itself the power to ban doctors if they prescribe medications in abusive ways. The action follows a ProPublica series that found inappropriate prescribing, waste and fraud.
Comments |
May 16, 2014 — The Food and Drug Administration's approval of a new drug for leishmaniasis came with a voucher that can be redeemed to speed up the approval of a much more lucrative drug in the future.
Comments |
May 12, 2014 — Once a drug is approved by the FDA, doctors can use it as they see fit. That can be brilliant or risky, depending on the medication and the patient.
Launch in player | Comments |
May 6, 2014 — German drug company Bayer makes a deal with U.S.-based Merck & Co. The purchase includes brands such as Claritin, Coppertone and Dr. Scholl's.
Comments |
Apr 28, 2014 — Pfizer, founded in Brooklyn, N.Y., in 1849, would become a British company by combining with AstraZeneca. The new company would get a much lower tax rate by moving its legal headquarters overseas.
Comments |
Apr 23, 2014 — Sovaldi has been found to be remarkably effective in curing most patients with common forms of hepatitis C in a matter of months. But the clinical success comes at a high price.
Comments |
Apr 8, 2014 — New drugs are usually tested in animals before they're tested in humans. But many of those studies aren't done carefully enough, analysts say. So time and money is wasted, and treatments are delayed.
Launch in player | Comments |
more Pharmaceuticals from NPR